Amicar and Atelectasis - a phase IV clinical study of FDA data

Summary:

Atelectasis is reported as a side effect among people who take Amicar (aminocaproic acid), especially for people who are male, 50-59 old, have been taking the drug for < 1 month also take Pepcid, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Atelectasis when taking Amicar. It is created by eHealthMe based on reports of 1,317 people who have side effects when taking Amicar from the FDA, and is updated regularly.

What is Amicar?

Amicar has active ingredients of aminocaproic acid. eHealthMe is studying from 1,323 Amicar users. Check the latest studies of Amicar.

What is Atelectasis?

Atelectasis (partial or complete collapse of the lung) is found to be associated with 1,467 drugs and 1,631 conditions by eHealthMe. Check the latest studies of Atelectasis.

On Apr, 11, 2026

1,317 people reported to have side effects when taking Amicar.
Among them, 22 people (1.67%) have Atelectasis.

Among these 22 people:

How long have people been on Amicar when they have Atelectasis? *

What is the gender of people who have Atelectasis when taking Amicar? *

female: 19.05 %
male: 80.95 %

What is the age of people who have Atelectasis when taking Amicar? *

What are other drugs people take besides Amicar? *

What are other side effects people have besides Atelectasis? *

Weight Decreased: 17 people, 77.27%
Fever: 16 people, 72.73%
Cough: 14 people, 63.64%
Oedema Peripheral (superficial swelling): 13 people, 59.09%
Pneumonia: 13 people, 59.09%
Chest Pain: 11 people, 50.00%
Back Disorder: 11 people, 50.00%
Anaemia (lack of blood): 11 people, 50.00%
Pulmonary Haemorrhage (acute bleeding from the lung): 11 people, 50.00%
Injury: 11 people, 50.00%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 9 people, 40.91%
Pain: 6 people, 27.27%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 5 people, 22.73%
High Blood Cholesterol: 2 people, 9.09%
Haemorrhage (bleeding): 2 people, 9.09%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 2 people, 9.09%
Breast Cancer Metastatic: 2 people, 9.09%
Aortic Valve Incompetence: 2 people, 9.09%
Neuralgia (pain in one or more nerves): 1 person, 4.55%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 1 person, 4.55%

* Approximation only. Some reports may have incomplete information.

Do you take Amicar and have Atelectasis?

- Check whether Atelectasis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Amicar:

Amicar (1,323 reports)

Atelectasis treatments and more:

Atelectasis (17,087 reports)

Browse all side effects of Amicar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Atelectasis:

Atelectasis (1,467 drugs)

Browse all the conditions that are associated with Atelectasis:

Atelectasis (1,631 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on aminocaproic acid (the active ingredients of Amicar) and Amicar (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.